RecruitingPhase 2ketamine
Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)
Sponsored by Stanford University
NCT ID
NCT05940324
Target Enrollment
150 participants
Start Date
2024-02-24
Est. Completion
2028-11
About This Study
The purpose of this study is to understand how ketamine works in the brain to bring about a reduction in OCD symptoms.
Conditions Studied
Interventions
- •Ketamine
- •Naltrexone Pill
- •Placebo pill
Eligibility
Age:18 Years - 65 Years
Healthy Volunteers:Yes
View full eligibility criteria
Eligibility Criteria for Participants with OCD: Inclusion Criteria: * Ages 18-65 * Meet the criteria for OCD diagnosis * Failed at least 1 prior trial of standard first-line OCD treatment * Agree to the following lifestyle modifications: comply with requirements for fasting prior to the Experimental Session, not enroll in any other interventional clinical trials during the duration of the study, and commit to medication study procedures. * Able to provide informed consent Exclusion Criteria: * prior naltrexone or ketamine use/exposure * Any current or past medical/psychiatric condition that makes participation unsafe in the opinion of the investigator or study physician * Pregnant or nursing, or able to become pregnant and are not practicing an effective means of birth control * the presence of metal in the body that is contraindicated for MRI scans Eligibility Criteria for Healthy Volunteers: Inclusion Criteria: * Ages 18-65 * Able to provide informed consent Exclusion Criteria: * current or past use of psychotropic medication * pregnant or nursing females * the presence of metal in the body that is contraindicated for MRI scans
Study Locations (1)
Department of Psychiatry & Behavioral Sciences
Stanford, California, United States